
Gene-Based Blood Test Shows Promise in Detecting Early Recurrence of Melanoma
A groundbreaking advancement in the fight against melanoma—a notoriously aggressive skin cancer—has emerged from the laboratories of NYU Langone Health. Researchers have demonstrated that monitoring circulating tumor DNA (ctDNA) fragments in a patient’s …